Zevia director sells 40,000 Class A shares

Zevia PBC director Padraic L. Spence sold 40,000 shares of Class A Common Stock in an open-market transaction on March 3, 2026 at a weighted average price of $1.4379 per share.

Rhea-AI Filing Summary

Zevia PBC director Padraic L. Spence sold 40,000 shares of Class A Common Stock in an open-market transaction on March 3, 2026 at a weighted average price of $1.4379 per share. After this sale, he directly holds 1,555,417 shares, including 71,827 restricted stock units that will vest over time under previously established schedules.

Insider Trade Summary

Net Seller: 40,000 shares

Net Sell 1 txn

Insider Spence Padraic L.

Role Director

Sold 40,000 shs ($58K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	40,000	$1.4379	$58K

Holdings After Transaction: Class A Common Stock — 1,555,417 shares (Direct)

Footnotes (2)

1. F1. The price reported in Column 4 is a weighted average sale price of the Issuer's Class A Common Stock. These shares were sold in multiple transactions at prices ranging from $1.43 to $1.45, inclusive. The Reporting Person undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. F2. Includes 71,827 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A Common Stock of the Issuer. 148,417 RSUs began vesting in 1/4 increments on each anniversary of March 17, 2022 and are settled within 30 days following each vesting date. 34,722 RSUs vest on the earlier to occur of (i) June 12, 2026 or (ii) the Issuer's 2026 annual meeting of stockholders and are settled within 30 days following such vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Zevia (ZVIA) shares did Padraic L. Spence sell in this Form 4?

Padraic L. Spence sold 40,000 shares of Zevia Class A Common Stock. The transaction was reported as an open-market sale at a weighted average price of $1.4379 per share, with individual trades occurring between $1.43 and $1.45.

What price did the Zevia (ZVIA) director receive for the shares sold?

The director received a weighted average sale price of $1.4379 per share. The 40,000 Zevia Class A Common shares were sold in multiple trades at prices ranging from $1.43 to $1.45, as detailed in the Form 4 footnote.

How many Zevia (ZVIA) shares does Padraic L. Spence own after this transaction?

After the sale, Padraic L. Spence directly owns 1,555,417 Zevia Class A Common shares. This total includes 71,827 restricted stock units, each representing the right to receive one share upon vesting under the specified schedules.

What restricted stock units (RSUs) are included in Padraic L. Spence’s Zevia (ZVIA) holdings?

His holdings include 71,827 RSUs, each convertible into one Class A share. 148,417 RSUs began vesting in quarter increments annually from March 17, 2022, and 34,722 RSUs vest on the earlier of June 12, 2026 or the 2026 stockholders’ meeting.

Was the Zevia (ZVIA) insider sale on March 3, 2026 a single trade or multiple trades?

The reported sale was executed through multiple trades. The Form 4 states a weighted average price of $1.4379 per share, with individual sale prices ranging from $1.43 to $1.45, and offers to provide the full breakdown on request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 07:56 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Spence Padraic L.

(Last) (First) (Middle)

C/O ZEVIA PBC

15821 VENTURA BLVD., SUITE 135

(Street)

ENCINO CA 91436

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Zevia PBC [ ZVIA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/03/2026		S		40,000	D	$1.4379(1)	1,555,417(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average sale price of the Issuer's Class A Common Stock. These shares were sold in multiple transactions at prices ranging from $1.43 to $1.45, inclusive. The Reporting Person undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. Includes 71,827 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A Common Stock of the Issuer. 148,417 RSUs began vesting in 1/4 increments on each anniversary of March 17, 2022 and are settled within 30 days following each vesting date. 34,722 RSUs vest on the earlier to occur of (i) June 12, 2026 or (ii) the Issuer's 2026 annual meeting of stockholders and are settled within 30 days following such vesting date.

	/s/ Carnation Jafari, Attorney-in-Fact for Padraic L. Spence	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.